This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2001-2003.
Company Filing History:
Years Active: 2001-2003
Title: Swen Hölder: Innovator in Pharmaceutical Chemistry
Introduction
Swen Hölder is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on thiadiazolesulfonamides. With a total of 2 patents to his name, Hölder continues to push the boundaries of chemical research.
Latest Patents
Hölder's latest patents include the development of substituted thiadiazolesulfonamides. These compounds, represented by the formula (I), showcase his expertise in creating novel chemical entities that have potential applications in various therapeutic areas.
Career Highlights
Swen Hölder is currently employed at Aventis Pharma Deutschland GmbH, where he applies his knowledge and skills to advance pharmaceutical research. His work at this esteemed company has allowed him to contribute to the development of innovative solutions in the healthcare sector.
Collaborations
Throughout his career, Hölder has collaborated with esteemed colleagues such as Werner Thorwart and Klaus-Ulrich Weithmann. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Swen Hölder is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions, particularly in the area of thiadiazolesulfonamides, reflect his commitment to advancing medical science.